Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
Clinical trial NCT03422029 · UNKNOWN
Trial details
- NCT number
- NCT03422029
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2020-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.